Skip to content

Penumbra PEN Total debt

Total debt at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
Stryker logo
StrykerSYK
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$374.8M+15.6%
Gross profit$253.4M+17.4%
Operating income$38.2M-5.2%
Net income$32.6M-16.9%
EPS (diluted)$0.82-18.0%

Balance sheet

See full
Cash & equivalents$241.3M-35.8%
Total equity$1.5B+21.5%
Total assets$1.9B+19.2%

Cash flow

See full
Operating cash flow$87.0M+77.6%
CapEx$13.7M+1.5%
Free cash flow$73.3M+106%

Valuation

See full
Market cap$12.48B+25.1%
Enterprise value$12.45B+26.8%
P/E72.9×-163×
P/S8.6×+0.5×

Profitability

See full
Gross margin67.4%+3.7pp
Operating margin12.9%+9.8pp
Net margin11.8%+8.4pp
FCF margin14.6%+2.5pp

Returns & leverage

See full
Return on equity12.7%+9.2pp
Debt / equity0.1×0.0×
Current ratio-0.3×

Where this comes from

Calculated from Penumbra’s reported figures.

Plus components not separately reported this period.

The official record: Penumbra’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Penumbra's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Penumbra's total debt?
Penumbra (PEN) reported total debt of $216.18M in Q1 2026.
How has Penumbra's total debt changed year-over-year?
Penumbra's total debt decreased by 2.0% year-over-year, from $220.66M to $216.18M.
What is the long-term trend for Penumbra's total debt?
Over 5 years (2020 to 2025), Penumbra's total debt has grown at a 23.1% compound annual growth rate (CAGR), from $78.61M to $222.09M.
What does total debt mean?
The total amount of money a company owes to lenders and creditors through loans, bonds, and lease obligations.
How do you interpret total debt?
An increase in total debt suggests higher financial leverage and increased interest expense, which may heighten insolvency risk if not matched by proportional cash flow growth. A decrease indicates deleveraging, potentially improving the balance sheet's resilience and reducing interest burdens.
How does total debt compare across companies?
Peers in the medical device sector typically maintain manageable debt levels to fund R&D and clinical trials, with comparisons often normalized against EBITDA to assess debt-servicing capacity.